MKI67 and neoplasm: The use of Ki-67 to guide decisions on adjuvant chemotherapy in specific situations is endorsed by the European Group on Tumor Markers [204], yet is not supported by the American Society of Clinical Oncology or National Comprehensive Cancer Center Guidelines [264,265].